Grants - AWARD SUMMARY


UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER


This application addresses broad Challenge Area (04) Clinical Research and specific Challenge Topic 04-AR-101 Autoimmunity for Diseases of Skin, Joints, Muscles and Other Tissues. It is estimated that approximately 5% of the US population is affected by an autoimmune disorder such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or multiple sclerosis (MS). These conditions cause considerable morbidity and excess mortality, as well as direct and indirect health care costs in the tens of billions of dollars. The diagnosis of these conditions is often difficult, requiring multiple visits to medical specialists, and the interpretation of imperfect tests. Even when the diagnosis is certain, the tools to offer prognosis or personalize therapy are often lacking. The overall goal of this project is to rapidly and thoroughly evaluate a novel technology for the measurement of antibodies specific for SLE, a model for systemic autoimmunity. The technology is based on the ability of synthetic polymers of N-substituted glycine termed 'peptoids' to serve as specific ligands for immunoglobulin. Two specific aims will be undertaken: 1) Validation of a novel technology platform for IgG biomarker discovery using systemic lupus erythematosus as a model, and 2) Determine the ability of peptoid ligands to identify pre-clinical autoimmunity. To accomplish these aims, highly specific peptoid ligands will be synthesized, purified and attached to fluorescent beads to create a high-throughput screening platform. They will then be used to measure and characterize autoantibodies from subjects with clinically evident SLE as well as those with early or incomplete forms of the disease. Together, the results of this study will lead to the development of new tools for clinicians and clinical researchers to use in the assessment of autoimmune diseases. PUBLIC HEALTH RELEVANCE: Autoimmune diseases are common causes of illness that are difficult to diagnose and monitor. This study will test a completely new method to monitor changes in the composition of the blood of patients with systemic lupus erythematosus. Using this as a model system, it is hoped that other autoimmune diseases will benefit from early diagnosis and treatment.

Clarification of Codes

Choose a quarter and click "Go."


AWARD OVERVIEW

AWARD OVERVIEW
Award Number 1RC1AR058817-01 Funding Agency Department of Health and Human Services
Total Award Amount $974,414 Project Location - City Dallas
Award Date 09/21/2009 Project Location - State TX
Project Status Completed Project Location - Zip 75390-9020
Jobs Reported 0.00 Congressional District 30
Project Location - Country US

Recipient Information (Grants)

Recipient Information (Grants)
Recipient Name UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
Recipient DUNS Number 800771545
Recipient Address 5323 HARRY HINES BLVD
Recipient City DALLAS
Recipient State Texas
Recipient Zip 75390-7208
Recipient Congressional District 30
Recipient Country USA
Required to Report Top 5
Highly Compensated Officials
No

Projects and Jobs Information

Projects and Jobs Information
Project Title High Throughput Screening of Autoimmune Epitome - ARRA Stimulus Challenge Grant
Project Status Completed
Final Project Report Submitted Yes
Project Activities Description Medical Specialties Research
Quarterly Activities/Project Description The final Total ARRA Expenditure for this project is less than the Award Amount.The project was completed under budget.No more funds will be expended.We have tested the ability of newly discovered synthetic antigens to detect autoantibodies in different subject groups. In general, reactivity to the peptoid corresponded to the presence of classically defined anti-nuclear antibodies. The anti-peptoid antibody was purified on a peptoid column and tested for reactivity to a panel of ~100 known autoantigens printed on a microarray. There appears to be poly-reactivity to antigens that are known to bind DNA or RNA. While this is not unexpected, it documents the validity of the approach used to detect autoantibodies, and the final identity of the authentic protein antigens is underway. However, we have detected anti-peptoid reactivity in a small set of first-degree relatives of lupus patients. These subjects were healthy at the time of blood donation and did not have an ANA. They are genetically predisposed to autoimmunity. The reactivity seen with the peptoid ligands may represent the first evidence of altered humoral immunity in these people who may go on to develop clinically apparent disease.
Jobs Created 0.00
Description of Jobs Created N/A


Purchaser Information (Grants)

Purchaser Information
Contracting Office ID Not Reported
Contracting Office Name Not Available
Contracting Office Region Not Available
TAS Major Program 75-0903

Award Information

Award Information
Award Date 09/21/2009
Award Number 1RC1AR058817-01
Order Number
Award Type Grants
Funding Agency ID 75
Funding Agency Name Department of Health and Human Services
Funding Office Name Not Available
Awarding Agency ID 75
Awarding Agency Name Department of Health and Human Services
Amount of Award $974,414
Funds Invoiced/Received $967,614
Expenditure Amount $967,614
Infrastructure Expenditure Amount $0
Infrastructure Purpose and Rationale Not Reported
Infrastructure Point of Contact Name Not Reported
Infrastructure Point of Contact Email Not Reported
Infrastructure Point of Contact Phone Not Reported
Infrastructure Point of Contact Address Not Reported
Infrastructure Point of Contact City Not Reported
Infrastructure Point of Contact State Not Reported
Infrastructure Point of Contact Zip Not Reported

Product or Service Information (Grants)

Product or Service Information
Primary Activity Code H03.07
Activity Description Medical Specialties Research

Sub-Awards Information

Sub-Awards Information
Sub-awards to Organizations 2
Sub-award Amounts to Organizations $471,582
Sub-Awards to Individuals 0
Sub-Award Amounts to Individuals $0
Number of Sub-awards less than $25,000/award 0
Amount of Sub-awards less than $25,000/award $0
Number of payments to vendors greater than $25,000 0
Total Amount of payments to vendors greater than $25,000/award $0
Number of payments to vendors less than $25,000/award 222
Total Amount of payments to vendors less than $25,000/award $513,975


Sub-Award Transactions

Sub-award GMO 100818 - PENNSYLVANIA STATE UNIVERSITY, THE

Sub-Award Amount $24,120
Sub-Award Date 07/01/2010
Sub-Awards Disbursed $20,041.68
Project Location - City Hershey
Project Location - State PA
Project Location - Zip Code 17033-2360
Project Location - Congressional District 15
Sub-Recipient DUNS Number 129348186
Sub-Recipient Address 500 UNIVERSITY DR C1607
Sub-Recipient City HERSHEY
Sub-Recipient State Pennsylvania
Sub-Recipient Zip Code 17033-2360
Sub-Recipient Congressional District 15
Required To Report Top 5
Highly Compensated Officials
No

Sub-award GMO 100908 - SCRIPPS RESEARCH INSTITUTE, THE

Sub-Award Amount $447,462
Sub-Award Date 09/21/2009
Sub-Awards Disbursed $447,461.82
Project Location - City Jupiter
Project Location - State FL
Project Location - Zip Code 33458-5284
Project Location - Congressional District 18
Sub-Recipient DUNS Number 781613492
Sub-Recipient Address 10550 N TORREY PINES RD
Sub-Recipient City LA JOLLA
Sub-Recipient State California
Sub-Recipient Zip Code 92037-1000
Sub-Recipient Congressional District 49
Required To Report Top 5
Highly Compensated Officials
No





Project Location Detail

Location Information
Latitude, Longitude 32º 48' 45", -96º 50' 18"
Congressional District 30
Address 1 5323 Harry Hines BLVD
Address 2
City Dallas
County Dallas
State TX
Zip 75390-9020
Submit Feedback/Comments: Provide feedback or comments on the performance and progress of awards.